Evidence map›Paper›PMID 9857172›Full record

ReviewThe EMBO journal1998

The ubiquitin-proteasome pathway: on protein death and cell life.

A Ciechanover

Registry-linked trialAbstract readReview
In one paragraph

Review in The EMBO journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03200639 (Comparison of High Intensity Interval Body Weight Training Versus Combined Training on Body Composition, Physical Function, Metabolic Risk and Inflammation in Postmenopausal Women With and Without Gynecological Cancer), which is not on this map. Cited by 469 papers.

0numbers the graph read from it
0cells of the map it votes in
469citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03200639 nacompletednot on this mapstarted 2015, after this paper: background citation

Comparison of High Intensity Interval Body Weight Training Versus Combined Training on Body Composition, Physical Function, Metabolic Risk and Inflammation in Postmenopausal Women With and Without Gynecological Cancer

TypeinterventionalSponsorUniversidade Federal do Triangulo MineiroRan2015 to 2015Enrolled38ConditionsBreast Cancer Female, Gynecologic Cancer, Menopause, Physical ActivityArmsCombined training, High intensity interval training with body weight
3 · Its place in the literature

Who cites it

469 citing papers in PubMed.

  1. Review
  2. Article
  3. Synthetic Strategies for Activity-Based Probes to Decode Ubiquitin-Like Modifiers.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Synthesis of Ub-ACA, a Fluorogenic DUB Substrate via ACPL Method.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Approaches To Managing Relapsed Myeloma: Switching Drug Class or Retreatment With Same Drug Class?Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025
    Review
  20. Article

409 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A CiechanoverDepartment of Biochemistry, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, P.O.Box 9649, Efron Street, Bat Galim, Haifa 31096, Israel.mdaaron@tx.technion.ac.il

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cysteine EndopeptidasesDiseaseLigasesModels, BiologicalMultienzyme ComplexesProteasome Endopeptidase ComplexProtein Processing, Post-TranslationalProteinsSubstrate SpecificityUbiquitinsCysteine EndopeptidasesLigasesMultienzyme ComplexesProteasome Endopeptidase ComplexProteinsUbiquitins

Identifiers

PMID9857172
PMCPMC1171061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.